
Tim F. Greten, MD, discusses the role of the gut microbiome in antitumor immunity in liver cancer.

Your AI-Trained Oncology Knowledge Connection!


Tim F. Greten, MD, discusses the role of the gut microbiome in antitumor immunity in liver cancer.

Tim F. Greten, MD, senior investigator, Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, discusses the impact of the gut microbiome on liver tumors.

Tim F. Greten, MD, senior investigator thoracic and gastrointestinal oncology branch, head, gastrointestinal malignancy section, National Cancer Institute, discusses promising immunotherapy agents being investigated in hepatocellular carcinoma (HCC).

Tim F. Greten, MD, senior investigator thoracic and gastrointestinal oncology branch, head, gastrointestinal malignancy section, National Cancer Institute (NCI), discusses the potential for immunotherapy in hepatocellular carcinoma (HCC).

Published: May 19th 2017 | Updated:

Published: December 12th 2018 | Updated:

Published: September 30th 2019 | Updated:

Published: November 14th 2016 | Updated: